United States
USA
Octapharma detected suspicious network activity on 17 April 2024 and shut down affected systems, resulting in closure of its U.S. plasma donation centers. The company progressively reopened sites and said all 176 U.S. centers had resumed normal operations by 25 April; European production sites remained unaffected and production was maintained. BlackSuit later claimed responsibility, but Octapharma did not publicly confirm the attribution.
Estimated severity
80 / 100
Source reliability
95 / 100
Approximate Date
17/04/2024
Targeted Company
OCTAPHARMA PLASMA
Distribution & Fulfillment
Procurement & Sourcing
Production & Manufacturing
Sales (Retail & Ecommerce)
Warehousing
Service Delivery
Unrecognized Impact
Supply Chain Relations
No information
United States
USA
No other affected countries reported
Target country
United States
Affected countries
Impacted regions
No information
Duration
8 days
Financial impact (USD M)
No information
Impact types
Affected sectors
Affected departments
Attack types
Attributed threat actors
Please rotate your phone